The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBASK.L Regulatory News (BASK)

  • There is currently no data for BASK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of exercise period of warrants

27 Aug 2019 07:00

RNS Number : 1406K
Baskerville Capital PLC
27 August 2019
 

 

27 August 2019

BASKERVILLE CAPITAL PLC

("Baskerville" or "the Company")

Extension of exercise period of warrants

 

 

Baskerville (BASK) has warrants outstanding over 2,000,000 ordinary shares exercisable at 2.5p per share and over 11,500,000 ordinary shares exercisable at 7.5p per share. These warrants will expire on the second anniversary of the Company's listing, being 22 September 2019.

 

The directors have today executed a deed poll to extend the exercise period of the warrants to the fourth anniversary of listing, being 22 September 2021. The directors have extended the exercise period because they believe the warrant-holders may support the Company in any future fundraising.

 

Rodger Sargent, Chairman of Baskerville said: "We continue to pursue technology deals and are closer, though not yet concluded, to agreeing our first deal. We will of course update shareholders further as soon as possible."

 

 

 

For information please contact:

 

Baskerville Capital plc

www.baskcap.com

Rodger Sargent

via Walbrook PR

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or baskerville@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEPFMMTMBTTBML
Date   Source Headline
8th Feb 202111:00 amRNSResult of General Meeting
26th Jan 20211:03 pmRNSDocuments for Inspection
21st Jan 20216:10 pmRNSProposed Acquisition of Oberon Investments
7th Jan 20212:34 pmRNSCancellation of Listing & Admission to Aquis
28th Oct 20202:15 pmRNSFinal Results
8th Jul 20207:00 amRNSUpdate on Proposed Acquisition
3rd Mar 20209:37 amRNSHalf-year Report
27th Jan 20207:30 amRNSInvestment, Proposed Acquisition and Suspension
28th Nov 20191:07 pmRNSResult of AGM
24th Oct 201912:07 pmRNSFinancial results for the year ended 30 June 2019
27th Aug 20197:00 amRNSExtension of exercise period of warrants
27th Mar 201911:35 amRNSHalf-year Report
5th Oct 20187:00 amRNSFinal Results
10th May 20187:00 amRNSHalf-year Report
6th Nov 201711:30 amRNSHolding(s) in Company
3rd Oct 201710:04 amRNSDirector/PDMR Shareholding
22nd Sep 20178:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.